Resolution of chronic nasal Staphylococcus aureus infection in a non-smoker who started to use glycerine based e-cigarettes: Antibacterial effects of vaping?

Medical Hypotheses

Volumn 118, Issue , 2018, Pages 42-43

  Miler, Joanna Astrid ^a   Hajek, Peter ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFALEXIN; COTRIMOXAZOLE; GLYCEROL; ANTIINFECTIVE AGENT; NICOTINE;

ADULT; AEROSOL; ARTICLE; CASE REPORT; CLINICAL ARTICLE; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; MALE; MIDDLE AGED; NOSE INFECTION; NOSE OBSTRUCTION; REINFECTION; STAPHYLOCOCCUS INFECTION; VAPING; CHEMISTRY; ELECTRONIC CIGARETTE; MICROBIOLOGY; NEBULIZER; NOSE DISEASE; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ELECTRONIC NICOTINE DELIVERY SYSTEMS; GLYCEROL; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; NICOTINE; NOSE DISEASES; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VAPING;

EID: 85048820013     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2018.05.011     Document Type: Article

References (21)

1. McNeill A, Brose LS, Calder R, Bauld L, Robson D. Public health Engl and – evidence review of e-cigarettes and heated tobacco products. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/679262/Evidence_review_of_e-cigarettes_and_heated_tobacco_products_2018.pdf; 2018 [Last accessed: 09.02.18].
2. Stephens, W.E., Comparing the cancer potencies of emissions from vapourised nicotine products including e-cigarettes with those of tobacco smoke. Tobacco Control 27 (2018), 10–17.
3. National Office of Statistics. Adult smoking habits in the UK: 2016: Cigarette smoking among adults including the proportion of people who smoke, their demographic breakdowns, changes over time, and e-cigarettes. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/bulletins/adultsmokinghabitsingreatbritain/2016; 2017 [Last accessed: 09.02.2018].
4. Polosa, R., Morjaria, J.B., Caponnetto, P., Prosperini, U., Russo, C., Pennisi, A., et al. Evidence for harm reduction in COPD smokers who switch to electronic cigarettes. Respir Res, 17, 2016, 166.
5. Miler, J.A., Mayer, B., Hajek, P., Changes in the frequency of airway infections in smokers who switched to vaping: results of an online survey. J Addict Res Ther, 7, 2016, 4.
6. Feldman, C., Anderson, R., Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems. J Infect 67 (2013), 169–184.
7. Miler, J.A., Hajek, P., Resolution of recurrent tonsillitis in a non-smoker who became a vaper. A case study and new hypothesis. Med Hypotheses 109 (2017), 17–18, 10.1016/j.mehy.2017.09.006.
8. Robertson, O.H., Bigg, E., Puck, T.T., Miller, B.F., The bactericidal action of propylene glycol vapor on microorganisms suspended in air. I. J Exp Med 75:6 (1942), 593–610.
9. Nalawade, T.M., Bhat, K., Sogi, S.H., Bactericidal activity of propylene glycol, glycerine, polyethylene glycol 400, and polyethylene glycol 1000 against selected microorganisms. J Int Soc Prevent Commun Dent 5 (2015), 114–119.
10. Kinyoun, J.J., The action of glycerin on bacteria in the presence of cell exudates. J Exp Med 7:6 (1905), 725–732, 10.1084/jem.7.6.725.
11. Singh BR. Antibacterial activity of glycerol, lactose, maltose, mannitol, raffinose and xylose. Noto-are 17223318: Medicine. 2014-07-19. 2014.
12. Schlievert, P.M., Peterson, M.L., Glycerol monolaurate antibacterial activity in broth and biofilm cultures. PLoS One, 7(7), 2012, e40350, 10.1371/journal.pone.0040350 Epub 2012 Jul 11.
13. Dailey, J.R., Rosenwasser, G.O., Viability of bacteria in glycerin and ethanol preserved sclera. J Refract Corneal Surg 10:1 (1994), 38–40.
14. Kosmider, L., Sobczak, A., Fik, M., Knysak, J., Zaciera, M., Kurek, J., et al. Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob Res 16:10 (2014), 1319–1326, 10.1093/ntr/ntu078.
15. Roberts, D., Cole, P., Effect of tobacco and nicotine on growth of Haemophilus influenza in vitro. J Clin Pathol 32 (1979), 728–731.
16. Bardell, D., Viability of six species of normal oropharyngeal bacteria after exposure to cigarette smoke in vitro. Microbios 32 (1981), 7–13.
17. Allen, B.W., Mitchison, D.A., Nicotine and mycobacteria. J R Soc Med 76 (1983), 893–894.
18. Pavia, C.S., Pierre, A., Nowakowski, J., Antimicrobial activity of nicotine against a spectrum of bacterial and fungal pathogens. J Med Microbiol 49:7 (2000), 675–676.
19. Zaidi, M.I., Wattoo, F.H., Wattoo, M.H.S., Tirmizi, S.A.T., Salman, S., Antibacterial activities of nicotine and its zinc complex. Afr J Microbiol Res 6:24 (2012), 5134–5137, 10.5897/AJMR11.1209.
20. Margham, J., McAdam, K., Forster, M., Liu, C., Wright, C., Mariner, D., et al. Chemical composition of aerosol from an E-cigarette: a quantitative comparison with cigarette smoke. Chem Res Toxicol 29:10 (2016), 1662–1678, 10.1021/acs.chemrestox.6b00188.
21. Williams, M., Villarreal, A., Bozhilov, K., Lin, S., Talbot, P., Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One, 8, 2013, e57987, 10.1371/journal.pone.0057987.